Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

Title of publication: 

Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

Authors: 

Zeissig S, Rosati E, Dowds CM, Aden K, Bethge J, Schulte B, Pan WH, Mishra N, Zuhayra M, Marx M, Paulsen M, Strigli A, Conrad C, Schuldt D, Sinha A, Ebsen H, Kornell SC, Nikolaus S, Arlt A, Kabelitz D, Ellrichmann M, Lützen U, Rosenstiel PC, Franke A, Schreiber S

Year of Publication: 

2018

medium resp. publishing house / place: 

Gut.

edition / issue: 

Jan 2019; Epub 5 / May 2018

Pages: 

25-39

related to project: 

Epigenetic marks of a stable host-microbiota association in the mammalian gut
Defining disease-associated T and B cell repertoires in chronic inflammatory bowel diseases

Pubmed: 

Pubmed - PMID